| Prometheus buys rights to kidney cancer drug in late-stage testing - San Diego Union Tribune |
|
|
San Diego Union Tribune Rencarex is a special antibody that binds with the CA IX-antigen, which is present on the surface of tumor cells in 95 percent of clear cell renal cell carcinoma, the most common form of kidney cancer. With no FDA-approved drug for the disease, |